Tag: Oncology

Machine Learning for Building Personalized Cancer Nanomedicines: Interview with Dr. Daniel Heller

Researchers at the Sloan Kettering Institute and the Weill Cornell Graduate School of Medical Sciences in New York have developed a machine learning approach to design personalized nanoparticle therapies for cancer. Personalized cancer therapies aim to provide a treatment that is tailored to the genetic makeup of a patient’s tumor. They can s (Read more...)

Nanoparticle-Based Imaging of Metastasis Throughout Body

Common radiological tumor detection technique these days is done using contrast-enhanced magnetic resonance imaging (MRI), which can only detect tumors of a certain size or larger. This is a major limitation, as it leaves patients with smaller tumors that grow and spread undetected, preventing early treatment of many cancers. Researchers at Rutgers (Read more...)

Cytotwister, A Unique 3D Stem Cell Bioreactor: Interview with Dr. Hsin-Hsin Shen of Industrial Technology Research Institute

Stem cells are up-and-coming therapies, and a major engineering problem has been scaling up the cell manufacturing to create enough cells for different therapeutic applications. Cytotwister, from the Industrial Technology Research Institute (ITRI) in Taiwan, makes a step towards solving that with a unique 3D stem cell bioreactor system that address (Read more...)

War on Cancer: A Patient’s Journey, Comes to London

On November 21st The Economist newspaper declared War on Cancer for the third time in London, drawing world experts in oncology policy, clinical practice, and innovation together in the unique and fitting venue of the Honorable Artillery Company. With over 200 known types of cancer and each patient’s unique physiology leading to huge var (Read more...)

Genome Editing Primes T-Cells to Attack Cancer

Scientists at Cardiff University in the UK have found a way to enhance the cancer-destroying ability of T-cells through DNA editing. The research team used CRISPR genome editing technique to remove the receptors naturally present on T-cells, and instead replace them with receptors that would recognize specific cancers cells, causing the T-cells to (Read more...)

Sensus Healthcare’s Technology Uses Low-Energy X-rays Directly on Cancer Cells: Interview with CEO Joe Sardano

Sensus Healthcare is a medical device company that focuses on providing non-invasive and cost-effective treatment of non-melanoma skin cancers and keloids utilizing superficial radiation technology (SRT). Their proprietary, FDA-cleared SRT technology is used to effectively and safely treat oncological and non-oncological skin conditions. The radiat (Read more...)

Microfluidic Device for Onco Chemo Testing

Chemotherapy can be very difficult on patients, but finding out that the cancer didn’t respond to the chemo is even more disturbing. Soon there may be a way to try different chemo agents on a patient’s own tumor cells taken during a biopsy. Researchers at Purdue University have developed a microfluidic system inside which tumor [&hellip (Read more...)